tiotropio

Tiotropium is a long-acting anticholinergic medication used to manage chronic obstructive pulmonary disease, or COPD, and asthma. It is administered via inhalation, typically once daily. Tiotropium works by blocking the action of acetylcholine, a neurotransmitter that causes the muscles in the airways to contract. By inhibiting acetylcholine, tiotropium helps to relax these muscles, leading to bronchodilation, which makes breathing easier.

The primary indication for tiotropium is the maintenance treatment of bronchospasm associated with COPD, which includes chronic bronchitis and emphysema. It is also approved for the long-term control of asthma in patients aged 12 years and older who are not adequately controlled with a combination of an inhaled corticosteroid and a long-acting beta-agonist. Tiotropium is not intended for the relief of acute bronchospasm or asthma attacks.

Common side effects of tiotropium include dry mouth, blurred vision, urinary retention, and constipation, which are typical anticholinergic effects. Less common side effects can include dizziness, headache, and throat irritation. It is important for patients to use tiotropium as prescribed and to discuss any concerns with their healthcare provider. The medication is available in various inhaled formulations, including dry powder inhalers and soft mist inhalers.